Not Tagged
xencor,blueprint medicines
['thanks', '$bpmc', '$xncr']
#asco23 highlights so far: $bpmc's overlooked oncology assets showing early signs of promise (icing on the cake after ism approval) $xncr ceo interview including value proposition of cd28 bispecifics (thanks ) claudins 6 &amp; 18.2 (mostly) living up to early hype 
Founder of 500+ member ROTY Biotech Community.

Focus on accelerating clinical & commercial momentum.

Learning from my highs and lows, add value where I can